Summit Investment Advisors »

Taro Pharmaceutical Industries shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $28k 675 41.78
2023-09-30 $26k 675 37.71
2023-06-30 $26k 675 37.93

More positions owned by Summit Investment Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Europe Pacific ETF (VEA)
Ishares Tr Etf (IVV)
Amazon (AMZN)
Vanguard S&p 500 Etf idx (VOO)
iShares Lehman Aggregate Bond (AGG)
NVIDIA Corporation (NVDA)
Alphabet Inc Class C cs (GOOG)
Spdr Ser Tr Etf (ONEV)
iShares S&P 500 Growth Index (IVW)
Broadcom (AVGO)
Vanguard Total Bond Market ETF (BND)
iShares S&P 500 Value Index (IVE)
Facebook Inc cl a (META)

View all positions for Summit Investment Advisors

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
Dimensional Fund Advisors
Brandes Investment Partners
Vanguard Group
ARK Investment Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management
Swiss National Bank
Citadel Advisors
Barclays
Connor, Clark & Lunn Investment Management
Inspire Advisors

View all funds holding Taro Pharmaceutical Industries